Search Results 461-470 of 17247 for Thoracentesis

  1. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  2. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

    ... thoracentesis or pericardiocentesis within last 2 months * Patients with LDH greater than 2.0-fold ULN * Concurrent treatment in another clinical trial or a ...

  3. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    ... thoracentesis within 3 months prior to study entry, except for subjects with a pleurex port; and immune-mediated toxicity leading to treatment discontinuation.

  4. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

  5. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Subjects with pleural effusions requiring thoracentesis or ascites requiring paracentesis within 14 days prior to randomization; Patients with coagulation ...

  6. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  7. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    Note: the following are not considered to be major procedures and are permitted up to 7 days before therapy initiation: Thoracentesis, paracentesis, port ...

  8. Heart attack - Doctors and departments - Mayo Clinic

    ... Thoracentesis, Lumbar puncture..., Paracentesis, Arterial line placement, Intracranial hemorrhage, Heart attack, Shock. Show more areas of focus for Courtney ...

  9. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    ... thoracentesis. Serious infection within 2 weeks prior to randomization, including any Grade 3 or higher (per NCI CTCAE version 4.0)11 viral, bacterial, or ...

  10. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma - Mayo Clinic

    Note: the following are not considered to be major procedures and are permitted up to 7 days before therapy initiation: Thoracentesis, paracentesis, port ...